相关实验视频
Updated: Jun 24, 2025

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.4K
化EM结构揭示了唐氏综合征的丝采用阿尔茨海默氏症的折叠
Ujjayini Ghosh1, Eric Tse1, Hyunjun Yang1
1Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA.
Acta neuropathologica communications
|June 12, 2024
概括
患有唐氏综合征 (DS) 的人因tau蛋白的变化而发展出类似阿尔茨海默氏症的痴呆症. 分子分析揭示了DS大脑中的tau结构与阿尔茨海默病 (AD) 的相同,这表明了共同的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 唐氏综合症 (DS) 是一种与早期阿尔茨海默病 (AD) 风险增加相关的遗传疾病.
- 痴呆症的痴呆与粉样β前体蛋白基因剂量增加以及陶蛋白聚合成神经毒性斑块和结有关.
- 陶蛋白在各种神经退行性疾病中形成了独特的纤维状结构.
研究的目的:
- 描述唐氏综合征患者脑样本中陶氏纤维的分子结构.
- 为了比较DS中陶纤维素构造与阿尔茨海默病中发现的构造.
- 调查DS和AD之间潜在的共享分子病理和治疗点.
主要方法:
- 用特定形状的染料进行光谱共聚焦成像.
- 电子显微镜 (cryo-EM) 用于高分辨率的结构确定孤立的纤维.
- 一种使用石墨烯氧化物和抗抗体进行分离的新型亲和网格方法.
主要成果:
- 高分辨率的冷EM结构揭示了DS大脑中的螺丝丝 (PHF) 和直线丝丝 (SF) 形状,与AD中相同.
- 这些纤维由两个C形原纤维组成,具有交叉β/β螺旋纹理.
- 虽然PHFs占主导地位 (约80%),但观察到的是少数SFs,类似于AD. 最年轻的个体,没有痴呆症,显示稀疏的沉积物,主要是PHF和一些CTE类型II类纤维.
结论:
- 唐氏综合症大脑中陶氏聚合物的分子结构与阿尔茨海默病大脑中的分子结构是不可区分的.
- 这些发现突显了DS和AD之间在陶纤维结构水平上共享的分子病理.
- 鉴定到的常见的丝折叠为开发针对性小分子治疗和诊断这两种疾病提供了机会.
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Alzheimer's Disease: Overview
462
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
462
Protein Folding
117.8K
Overview
117.8K

